Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter.
Posts Tagged ‘NYSE:WST’
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Hold West Pharmaceutical Services (WST) for the Long Term?
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2024 Earnings Call Transcript July 25, 2024West Pharmaceutical Services, Inc. misses on earnings expectations.
Does West Pharmaceutical Services (WST) Have Attractive Growth Drivers?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
25 Best Dividend Aristocrats to Buy According to Analysts
The age-old debate of investing in dividend growth or high-yield stocks continues to reappear within the dividend investing realm.
Here’s Why West Pharmaceutical Services (WST) Bounced Back in Q1
Conestoga Capital Advisors, an asset management company, released its “Mid-Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.56, expectations were $1.26. West Pharmaceutical Services, Inc.
What Makes West Pharmaceutical Services (WST) an Attractive Bet?
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here...
5 Most Reliable Dividend Stocks To Buy
In this article, we discuss 5 most reliable dividend stocks to buy.
West Pharmaceutical Services (WST) Fell on Reduced Full Year Guidance
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical Services, Inc. beats earnings expectations. Reported EPS is $1.83, expectations were $1.78. West Pharmaceutical Services, Inc.
Ken Griffin’s Wellington Fund Delivers Mind-Numbing Returns: Here are Its Top 15 Stocks
In this article, we will explore Ken Griffin's Wellington Fund delivers mind-numbing returns and its top 15 stocks.
Here’s Why West Pharmaceutical Services (WST) Fell in Q4
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
13 Best Dividend Stocks with Upside Potential
In this article, we discuss 13 best dividend stocks with upside potential.
5 Best Performing Dividend Stocks in 2023
In this article, we discuss 5 best-performing dividend stocks in 2023.
11 Best November Dividend Stocks To Buy
In this article, we discuss 11 best November dividend stocks to buy.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Third Quarter 2023 West Pharmaceutical Services Earnings Conference Call.
10 Best Dividend Aristocrats According to Analysts
In this article, we discuss best dividend aristocrats according to analysts.
West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the DTE Energy Second Quarter 2023 Earnings Conference Call.
Should You Hold West Pharmaceutical Services (WST) for the Long-Term?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Top 20 Countries With Highest Drug Consumption
In this piece, we will take a look at the top 20 countries with the highest drug consumption.
25 S&P 500 Dividend Aristocrats To Avoid
In this article, we discuss 25 dividend aristocrats to avoid according to hedge funds.
West Pharmaceutical Services (WST) Beat Revenue Expectations
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2023 Earnings Call Transcript
Quintin Lai: …conference call.
What Makes West Pharmaceutical Services (WST) an Attractive Investment?
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Dividend Stocks of 2023
In this article, we discuss 5 best dividend stocks of 2023.
Does West Pharmaceutical Services (WST) Have a Long Runway for Growth?
Baron Funds, an investment management company, released its “Baron Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2022 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to West Pharmaceutical Services Fourth Quarter 2022 Earnings Conference Call. .
5 Dividend Knights that Beat the Market Last 5 Years
In this article, we discuss 5 dividend stocks that beat the market last five years.
Dividend Kings and Aristocrats List: 50 Biggest Stocks
In this article, we will discuss 50 biggest dividend kings and dividend aristocrats.
Will West Pharmaceutical Services (WST) Able to Attain COVID Induced Growth?
Conestoga Capital Advisors, an asset management company, released its “Conestoga Mid Cap Growth Fund” third-quarter investor letter.
Should You Add West Pharmaceutical Services (WST) Shares to Your Portfolio?
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
11 Best American Dividend Stocks to Buy Now
In this article, we discuss 11 best American dividend stocks to buy now.
BofA Is Recommending These 15 Stocks
The Bank of America Corporation, or BofA, is an American multinational investment bank and financial services firm.
West Pharmaceutical Services (WST) Reported Higher Growth Driven by Price Increases
Baron Funds, an asset management company, released its “Baron Growth Fund” second quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Biotech Stocks to Buy Today According to Ken Fisher
In this piece, we will take a look at the ten biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Is it “Take Profit” Season for West Pharmaceutical (WST)?
Baron Funds, an asset management firm, published its “Baron Asset Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Hedge Funds Are Souring On West Pharmaceutical Services Inc. (WST)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need ...
Baron Funds: “West (WST) has a Long Runway for Growth”
Baron Funds, an asset management firm, published its “Baron Asset Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Where Do Hedge Funds Stand On West Pharmaceutical Services Inc. (WST)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Here’s Why Artisan Partners Trimmed its West Pharmaceutical Services (WST) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Baron Funds: “We Expect TransUnion (TRU) to Continue Gaining Market Share in its Core Market”
Baron Funds, an asset management firm, published its “Baron Asset Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
“West Pharmaceutical (WST)’s Core Business Performed Exceptionally Well”, According to Baron Funds
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
5 Pharma Companies Making Treatment for Opioid Overdose
In this article, we discuss the 5 pharma companies making treatment for opioid overdose.
